BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » BioInformant Releases “Stem Cell Research Products – Opportunities, Tools, & Technologies” with Market Size, Segments, Trends, & Projections to 2020
BioInformant Releases “Stem Cell Research Products, Opportunities, Tools, & Technologies - Market Size, Segments, Trends, and Projections to 2020”

BioInformant Releases “Stem Cell Research Products – Opportunities, Tools, & Technologies” with Market Size, Segments, Trends, & Projections to 2020

February 10, 2016 By Cade Hildreth (CEO) Leave a Comment

February 11, 2016; Washington, DC — BioInformant announces the February 2016 release of its global strategic report, “Stem Cell Research Products, Opportunities, Tools, and Technologies” with market size, segments, trends, and projections to 2020.

Discover class-defining bioproduction tools.

The first and only market research firm to specialize in the stem cell industry, BioInformant has more than a decade of historical information on all segments of the stem cell market, by stem cell type. This powerful 175 page global strategic report contains market size, segments, trends, and projections through 2020, as well a social analytics and an end-user survey of nearly 300 stem cell scientists. The “Survey of Stem Cell Scientists” identifies technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide.

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. Commonly investigated stem cell types include embryonic stem cells (ESCs), as well as adult stem cell types, such as mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs). A variety of other stem cell types exist as well.

Stem cells have generated substantial commercial interest, because their potential applications range from cell therapy applications, to tissue regeneration, drug development and discovery, pharmacological testing on cell-specific tissues, toxicology screening, and more. To facilitate research resulting from interest in these far-ranging applications, a large and growing stem cell research products market has emerged.

Rooster DevServices

Major players within the stem cell research products marketplace include Thermo Fisher Scientific, Miltenyi Biotec, Merck KGaA, Lonza Group, STEMCELL Technologies, BD Biosciences (a division of Becton Dickinson), Clontech (a Takara Bio Company), and GE Healthcare Life Sciences. Many small, mid-sized, and specialty providers also compete within the marketplace.

According to BioInformant’s President/CEO, Cade Hildreth, “We have helped hundreds of the top companies increase revenue from stem cell products and decrease risk. Stem cell market intelligence can position companies to approach institutional investors for fundraising, guide internal decision-making, and reduce the risk traditionally associated with new product development.”

bitbio

BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, Center for BioNetworking, and more.

Click here to view the full Executive Summary and Table of Contents now: https://bioinformant.wpengine.com/product/stem-cell-research-products-opportunities-tools-and-technologies/

Pluristyx

Want to be better informed than your competition? Get future stem cell industry updates.

 

iPSC-derived cardiomyocte therapy

About Us

BioInformant is the only research firm to serve the stem cell sector since it emerged. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.

Click here to view our global strategic reports for the stem cell industry.

5/5 - (1 vote)

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: market report, press release, research products, stem cells, STEMCELL Technologies, Thermo Fisher Scientific

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Featured Posts

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.